vs
UiPath, Inc.（PATH）与Penumbra Inc（PEN）财务数据对比。点击上方公司名可切换其他公司
UiPath, Inc.的季度营收约是Penumbra Inc的1.1倍（$411.1M vs $385.4M），UiPath, Inc.净利率更高（48.4% vs 12.3%，领先36.1%），Penumbra Inc同比增速更快（22.1% vs 15.9%），Penumbra Inc自由现金流更多（$68.0M vs $25.1M），过去两年Penumbra Inc的营收复合增速更高（17.6% vs 0.7%）
UiPath是一家全球化软件企业，专注于开发人工智能、智能自动化及流程编排类软件，其产品支持用户搭建与调度AI代理，实现复杂业务流程、工作流的自动化运行，助力各行业客户提升运营效率、降低人力成本。
Penumbra Inc是2004年由Arani Bose与Adam Elsesser联合创立的美国医疗器械企业，总部位于加利福尼亚州阿拉米达，核心业务为研发、生产中风、动脉瘤等血管疾病介入治疗所用的专业医疗设备，产品已在全球多个国家的临床诊疗场景中投入使用。
PATH vs PEN — 直观对比
营收规模更大
PATH
是对方的1.1倍
$385.4M
营收增速更快
PEN
高出6.2%
15.9%
净利率更高
PATH
高出36.1%
12.3%
自由现金流更多
PEN
多$42.9M
$25.1M
两年增速更快
PEN
近两年复合增速
0.7%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $411.1M | $385.4M |
| 净利润 | $198.8M | $47.3M |
| 毛利率 | 83.3% | 68.0% |
| 营业利润率 | 3.2% | 15.4% |
| 净利率 | 48.4% | 12.3% |
| 营收同比 | 15.9% | 22.1% |
| 净利润同比 | 1966.2% | 40.6% |
| 每股收益（稀释后） | $0.37 | $1.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PATHPEN
| Q4 25 | $411.1M | $385.4M | ||
| Q3 25 | $361.7M | $354.7M | ||
| Q2 25 | $356.6M | $339.5M | ||
| Q1 25 | $423.6M | $324.1M | ||
| Q4 24 | $354.7M | $315.5M | ||
| Q3 24 | $316.3M | $301.0M | ||
| Q2 24 | $335.1M | $299.4M | ||
| Q1 24 | $405.3M | $278.7M |
净利润PATHPEN
| Q4 25 | $198.8M | $47.3M | ||
| Q3 25 | $1.6M | $45.9M | ||
| Q2 25 | $-22.6M | $45.3M | ||
| Q1 25 | $51.8M | $39.2M | ||
| Q4 24 | $-10.7M | $33.7M | ||
| Q3 24 | $-86.1M | $29.5M | ||
| Q2 24 | $-28.7M | $-60.2M | ||
| Q1 24 | $33.9M | $11.0M |
毛利率PATHPEN
| Q4 25 | 83.3% | 68.0% | ||
| Q3 25 | 82.2% | 67.8% | ||
| Q2 25 | 82.1% | 66.0% | ||
| Q1 25 | 84.8% | 66.6% | ||
| Q4 24 | 82.0% | 66.8% | ||
| Q3 24 | 80.0% | 66.5% | ||
| Q2 24 | 83.5% | 54.4% | ||
| Q1 24 | 86.8% | 65.0% |
营业利润率PATHPEN
| Q4 25 | 3.2% | 15.4% | ||
| Q3 25 | -5.6% | 13.8% | ||
| Q2 25 | -4.6% | 12.0% | ||
| Q1 25 | 7.9% | 12.4% | ||
| Q4 24 | -12.2% | 13.6% | ||
| Q3 24 | -32.7% | 11.7% | ||
| Q2 24 | -14.8% | -27.0% | ||
| Q1 24 | 3.7% | 4.3% |
净利率PATHPEN
| Q4 25 | 48.4% | 12.3% | ||
| Q3 25 | 0.4% | 12.9% | ||
| Q2 25 | -6.3% | 13.3% | ||
| Q1 25 | 12.2% | 12.1% | ||
| Q4 24 | -3.0% | 10.7% | ||
| Q3 24 | -27.2% | 9.8% | ||
| Q2 24 | -8.6% | -20.1% | ||
| Q1 24 | 8.4% | 3.9% |
每股收益（稀释后）PATHPEN
| Q4 25 | $0.37 | $1.20 | ||
| Q3 25 | $0.00 | $1.17 | ||
| Q2 25 | $-0.04 | $1.15 | ||
| Q1 25 | $0.09 | $1.00 | ||
| Q4 24 | $-0.02 | $0.88 | ||
| Q3 24 | $-0.15 | $0.75 | ||
| Q2 24 | $-0.05 | $-1.55 | ||
| Q1 24 | $0.07 | $0.28 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $186.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.9B | $1.4B |
| 总资产 | $2.9B | $1.8B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PATHPEN
| Q4 25 | $1.4B | $186.9M | ||
| Q3 25 | $1.4B | $321.0M | ||
| Q2 25 | $1.6B | $421.8M | ||
| Q1 25 | $1.6B | $376.1M | ||
| Q4 24 | $1.6B | $324.4M | ||
| Q3 24 | $1.7B | $280.5M | ||
| Q2 24 | $1.9B | $288.3M | ||
| Q1 24 | $1.9B | $223.1M |
股东权益PATHPEN
| Q4 25 | $1.9B | $1.4B | ||
| Q3 25 | $1.7B | $1.4B | ||
| Q2 25 | $1.7B | $1.3B | ||
| Q1 25 | $1.8B | $1.2B | ||
| Q4 24 | $1.7B | $1.2B | ||
| Q3 24 | $1.8B | $1.1B | ||
| Q2 24 | $2.0B | $1.2B | ||
| Q1 24 | $2.0B | $1.2B |
总资产PATHPEN
| Q4 25 | $2.9B | $1.8B | ||
| Q3 25 | $2.6B | $1.7B | ||
| Q2 25 | $2.6B | $1.7B | ||
| Q1 25 | $2.9B | $1.6B | ||
| Q4 24 | $2.7B | $1.5B | ||
| Q3 24 | $2.7B | $1.5B | ||
| Q2 24 | $2.8B | $1.5B | ||
| Q1 24 | $3.0B | $1.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.3M | $86.5M |
| 自由现金流经营现金流 - 资本支出 | $25.1M | $68.0M |
| 自由现金流率自由现金流/营收 | 6.1% | 17.7% |
| 资本支出强度资本支出/营收 | 0.8% | 4.8% |
| 现金转化率经营现金流/净利润 | 0.14× | 1.83× |
| 过去12个月自由现金流最近4个季度 | — | $174.9M |
8季度趋势，按日历期对齐
经营现金流PATHPEN
| Q4 25 | $28.3M | $86.5M | ||
| Q3 25 | $41.6M | $58.3M | ||
| Q2 25 | $119.0M | $44.9M | ||
| Q1 25 | $146.1M | $49.0M | ||
| Q4 24 | $28.1M | $51.1M | ||
| Q3 24 | $46.4M | $56.5M | ||
| Q2 24 | $100.0M | $22.6M | ||
| Q1 24 | $145.6M | $38.3M |
自由现金流PATHPEN
| Q4 25 | $25.1M | $68.0M | ||
| Q3 25 | — | $42.0M | ||
| Q2 25 | $106.2M | $29.4M | ||
| Q1 25 | $138.7M | $35.5M | ||
| Q4 24 | $23.2M | $45.7M | ||
| Q3 24 | $45.0M | $51.0M | ||
| Q2 24 | $98.8M | $18.1M | ||
| Q1 24 | $141.8M | $32.5M |
自由现金流率PATHPEN
| Q4 25 | 6.1% | 17.7% | ||
| Q3 25 | — | 11.8% | ||
| Q2 25 | 29.8% | 8.7% | ||
| Q1 25 | 32.7% | 11.0% | ||
| Q4 24 | 6.5% | 14.5% | ||
| Q3 24 | 14.2% | 16.9% | ||
| Q2 24 | 29.5% | 6.0% | ||
| Q1 24 | 35.0% | 11.7% |
资本支出强度PATHPEN
| Q4 25 | 0.8% | 4.8% | ||
| Q3 25 | 0.0% | 4.6% | ||
| Q2 25 | 3.6% | 4.6% | ||
| Q1 25 | 1.7% | 4.2% | ||
| Q4 24 | 1.4% | 1.7% | ||
| Q3 24 | 0.4% | 1.8% | ||
| Q2 24 | 0.4% | 1.5% | ||
| Q1 24 | 0.9% | 2.1% |
现金转化率PATHPEN
| Q4 25 | 0.14× | 1.83× | ||
| Q3 25 | 26.25× | 1.27× | ||
| Q2 25 | — | 0.99× | ||
| Q1 25 | 2.82× | 1.25× | ||
| Q4 24 | — | 1.52× | ||
| Q3 24 | — | 1.91× | ||
| Q2 24 | — | — | ||
| Q1 24 | 4.29× | 3.48× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PATH
| Subscription Services | $247.6M | 60% |
| License | $150.0M | 36% |
| Professional Services And Other | $13.5M | 3% |
PEN
| Thrombectomy | $254.7M | 66% |
| Other | $130.7M | 34% |
